Arcus Biosciences Files 8-K

Ticker: RCUS · Form: 8-K · Filed: Feb 18, 2025 · CIK: 1724521

Sentiment: neutral

Topics: 8-K, operations, filing

TL;DR

Arcus Bio filed an 8-K on Feb 18th for events on Feb 15th. Details TBD.

AI Summary

Arcus Biosciences, Inc. filed an 8-K on February 18, 2025, reporting on results of operations and other events as of February 15, 2025. The filing does not contain specific financial figures or details about the 'other events' but serves as a notification of these items.

Why It Matters

This 8-K filing indicates that Arcus Biosciences has reported on its operational results and other significant events, which could impact investors' understanding of the company's current status.

Risk Assessment

Risk Level: low — The filing is a standard 8-K notification without specific financial details or material disclosures that would immediately indicate high risk.

Key Players & Entities

FAQ

What specific events are being reported by Arcus Biosciences, Inc. on February 15, 2025?

The filing indicates 'Results of Operations and Financial Condition' and 'Other Events' as the items being reported, but does not provide specific details within this 8-K document.

When was this Form 8-K filed with the SEC?

This Form 8-K was filed on February 18, 2025.

What is the principal executive office address for Arcus Biosciences, Inc.?

The principal executive offices are located at 3928 Point Eden Way, Hayward, California, 94545.

What is the IRS Employer Identification Number for Arcus Biosciences, Inc.?

The IRS Employer Identification Number is 47-3898435.

Under which section of the Securities Exchange Act is this report filed?

This Current Report is filed Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on February 18, 2025 regarding Arcus Biosciences, Inc. (RCUS).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing